The Liver Meeting 2021 (American Association for the Study of Liver Diseases)
https://corcept.com/wp-content/uploads/COR-logo.svg00jeremiah@devisedesigns.comhttps://corcept.com/wp-content/uploads/COR-logo.svgjeremiah@devisedesigns.com2023-01-28 00:00:002024-03-14 21:32:36Miricorilant, a selective GR modulator, induced a rapid and significant reduction in liver fat content in a randomized, placebo-controlled phase 2a study in patients with nonalcoholic steatohepatitis
